FDA Approval of Amyotrophic Lateral Sclerosis (ALS) Drug Represents Progress, But We’re Not Done
Neurodegenerative diseases result in progressive damage to specific cells and connections in the brain and spinal cord, and they exact an incalculable toll on patients, as well as their families and caregivers. Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that gradually robs people of their ability to walk, talk, move, swallow, and even to breathe on their own.
The third Season of the National Institute of Neurological Disorders and Stroke’s Building Up the Nerve podcast helps you strengthen your mentoring relationships with tools and advice from both trainees and faculty. We know that navigating your career can be daunting, but we're here to help—it's our job!